Back

The prognostic value of GDF15 in patients with heart failure and coronary artery disease after coronary artery bypass grafting

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - biomarkers (1) Biomarkers HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Associate Professor Yasmin Rustamova

Azerbaijan Medical University, Baku (Azerbaijan)

6 More presentations in this session

Presentation thumbnail
Comparision value of CA125 with NT-proBNP in predicting fluid overload in heart failure patients
Doctor T. Phan (Ho Chi Minh, VN)
Abstract Slides Video
Presentation thumbnail
The value of CA 125 in predicting fluid overload in heart failure
Doctor T. Phan (Ho Chi Minh, VN)
Abstract Slides Video
Presentation thumbnail
Chloride: an emergent biomarker with prognostic significance in acute cardiorenal syndrome
Doctor T. Georgopoulou (Heraklion, GR)
Abstract Slides Video
Presentation thumbnail
Prognostic role of NT-proBNP in the era of guideline directed medical therapy (GDMT) clinic
Doctor K. Kam (Shatin, HK)
Abstract Slides Video
Presentation thumbnail
Endothelial markers in type 2 diabetic patients with acute decompensated heart failure: a pilot study
Doctor J. Jurica (Martin, SK)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - biomarkers (1)

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Growth differentiation factor (GDF15) profile and prognostic implications across the left ventricular ejection fraction in chronic heart failure
thumbnail
Congress Presentation
Growth differentiation factor 15 and all-cause and cause-specific mortality in patients with suspected or known coronary artery disease: The ANOX and EXCEED-J Studies
thumbnail
Congress Presentation
Growth differentiation factor-15 and 5-years cardiovascular risk in chest pain patients presenting to the emergency department: a multicenter cohort study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources